Lundbeck, a prominent name in the Health Care industry, stands out with its dedication to advancing brain health. Founded in 1915 and headquartered in Denmark, this biopharmaceutical company has carved a niche in neuroscience, leveraging over 70 years of specialized experience.
Focused on neurological and psychiatric diseases, Lundbeck's mission is encapsulated in its slogan: "Advancing brain health. Transforming lives." The company is poised to make a significant difference as brain disorders increasingly impact global health. By exploring innovative treatments, Lundbeck addresses patients' needs through its robust research and development programs, targeting both neuro-specialty and neuro-rare conditions.
With a workforce exceeding 5,000 across 20-plus countries and products available in over 80 nations, Lundbeck is a well-positioned player in the global market. Though the company has not recently sought external investments, its longstanding commitment to innovation and health equity continues to create long-term shareholder value.